PAM
CBPO

Panagora Asset Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Panagora Asset Management’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-91
Closed -$9K – 2931
2020
Q2 		$9K Hold
91
– – ﹤0.01% 2256
2020
Q1 		$10K Buy
91
+42
+86% +$4.83K ﹤0.01% 2147
2019
Q4 		$6K Sell
49
-137
-74% -$15.9K ﹤0.01% 2230
2019
Q3 		$21K Buy
+186
New +$18.5K ﹤0.01% 2074
2016
Q2 		– Sell
-614
Closed -$70K – 2396
2016
Q1 		$70K Buy
+614
New +$72K ﹤0.01% 1952

Other funds holding CBPO

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
YCMGA
York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MCP
Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capstone Investment Advisors
Capstone Investment Advisors New York $57.4B AUM 26.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Panagora Asset Management's CBPO Position: Q3 2020 in Review

Panagora Asset Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2020, closing a stake of 91 shares — an estimated $9K sold.

Panagora Asset Management first reported a position in CBPO in Q1 2016 and held it in 5 quarters. The position peaked at $70K in Q1 2016. 87 funds tracked by Wall St. Rank hold CBPO as of Q3 2020.

  • Panagora Asset Management reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2020 after selling out during the quarter.
  • Panagora Asset Management sold 91 China Biologic Products Holdings, Inc. shares in Q3 2020, an estimated $9K.
  • Panagora Asset Management first reported a position in China Biologic Products Holdings, Inc. in Q1 2016 and held it in 5 quarters.
  • Panagora Asset Management's China Biologic Products Holdings, Inc. position peaked at $70K in Q1 2016.
  • 87 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2020.

Based on Panagora Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.